The potential to target CCL5/CCR5 in breast cancer

M Velasco-Velázquez, W Xolalpa… - Expert opinion on …, 2014 - Taylor & Francis
Introduction: Chemokines play a crucial role in breast cancer tumorigenesis and
progression. Recently, the chemokine (CC motif) ligand 5 (CCL5), which can be secreted …

Analysis of chemokine and chemokine receptor expression in squamous cell carcinoma of the head and neck (SCCHN) cell lines

HA Wolff, D Rolke, M Rave-Fränk, M Schirmer… - Radiation and …, 2011 - Springer
The purpose of this work was to analyze chemokine and chemokine receptor expression in
untreated and in irradiated squamous cell carcinoma of the head and neck (SCCHN) tumor …

[HTML][HTML] The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations

M Zare-Bidaki, M Karimi-Googheri… - Iranian journal of …, 2015 - ncbi.nlm.nih.gov
Evidence showed that chemokines serve as pro-migratory factors for immune cells. CCL3,
CCL4 and CCL5, as the main CC chemokines subfamily members, activate immune cells …

CCL5-403, CCR5-59029, and Delta32 polymorphisms and cancer risk: a meta-analysis based on 20,625 subjects

H Ying, J Wang, X Gao - Tumor Biology, 2014 - Springer
Abstract Associations between CCL5-403, CCR5-59029, and Delta32 polymorphisms and
cancer risk are inconclusive. To derive a more precise estimation of the association, we …

Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case–control study

V Asefi, Z Mojtahedi, B Khademi, S Naeimi… - The Journal of …, 2009 - cambridge.org
Objective: To investigate the association of two functional single nucleotide polymorphisms
in the promoter region of the interleukin-18 gene, at positions− 607 and− 137, with head and …

The SDF-1 rs1801157 Polymorphism is Associated with Cancer Risk: An Update Pooled Analysis and FPRP Test of 17,876 Participants

X Tong, Y Ma, H Deng, X Wang, S Liu, Z Yan, S Peng… - Scientific reports, 2016 - nature.com
The stromal cell derived factor-1 (SDF-1) rs1801157 gene polymorphism has been
implicated in susceptibility to cancer, but the results were inconclusive. The current study …

Evaluation of CCL5-403 G> A and CCR5 Δ32 gene polymorphisms in patients with breast cancer

E Eskandari-Nasab, M Hashemi, M Ebrahimi… - Cancer …, 2014 - content.iospress.com
Background: Recent evidence has demonstrated the implication of CC chemokine ligand 5
(CCL5) and CC chemokine receptor 5 (CCR5) in breast tumor initiation and progression …

Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan

F Fatima, S Saleem, A Hameed, G Haider… - Molecular biology …, 2019 - Springer
Chemokine CC receptor type 5 (CCR5) is a cell surface receptor that has high affinity for
chemotropic cytokines called chemokines. The CCR5 gene contains a 32 base pairs (bp) …

The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis

K Zhu, B Jiang, R Hu, Y Yang, M Miao, Y Li, Z Liu - PloS one, 2014 - journals.plos.org
Background CXCL12 is a small chemotactic cytokine belonging to the CXC chemokine
family expressed in various organs. It contributes to the migration, invasion and …

Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk

E Liarmakopoulos… - Molecular …, 2013 - spandidos-publications.com
Abstract Stromal-cell derived factor-1 (SDF-1), a CXC chemokine, is important for growth,
angiogenesis and metastasis of tumor cells. The SDF1-3'A polymorphism has been …